Related Experiment Video
Updated: Jun 29, 2025

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
Prebiotics and Probiotics for Gastrointestinal Disorders
Sameeha Rau1, Andrew Gregg1, Shelby Yaceczko1
1Vatche & Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA 90095, USA.
This review explores how prebiotics and probiotics impact the gut microbiome for gastrointestinal (GI) disorders. Evidence highlights strain-specific benefits and potential adverse effects of these supplements.
Area of Science:
- Microbiology
- Gastroenterology
- Nutrition Science
Background:
- The gut microbiome's role in gastrointestinal (GI) disorders is a key research area.
- Diet significantly influences gut microbiome composition and function.
- Prebiotics and probiotics show potential for managing GI conditions by modulating the microbiome.
Purpose of the Study:
- To review current evidence on prebiotics and probiotics for various GI disorders.
- To highlight strain-specific effects of these interventions.
- To identify any noted adverse effects associated with their use.
Main Methods:
- Systematic literature review of studies on prebiotics and probiotics in GI disorders.
- Analysis of evidence focusing on specific microbial strains, dosages, and treatment durations.
- Examination of reported safety data and adverse events.
Main Results:
- Significant heterogeneity exists across studies regarding strains, doses, and treatment duration.
- Prebiotics and probiotics demonstrate potential benefits, but effects are often strain-dependent.
- Safety concerns, particularly with live organisms, warrant careful consideration.
Conclusions:
- Strain-specific effects are crucial for understanding prebiotic and probiotic efficacy in GI disorders.
- Further research is needed to establish clear, evidence-based recommendations for their use.
- Careful consideration of safety and strain specificity is essential for clinical application.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Other Disorders of Digestive System

